Advertisement

Topics

FDA fast-tracks Sesen Bio's bladder cancer drug

06:38 EDT 10 Aug 2018 | SmartBrief

The FDA granted fast-track status to Sesen Bio's Vicinium, which is in late-stage trials and is being developed as a treatmen -More

Original Article: FDA fast-tracks Sesen Bio's bladder cancer drug

NEXT ARTICLE

More From BioPortfolio on "FDA fast-tracks Sesen Bio's bladder cancer drug"

Advertisement
Quick Search
Advertisement
Advertisement